Las Vegas, NV -- (SBWIRE) -- 01/07/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: iShares Russell 2000 Growth Index (ETF) (NYSEARCA:IWO), Advance Auto Parts, Inc. (NYSE:AAP), Biogen Idec Inc (NASDAQ:BIIB).
iShares Russell 2000 Growth Index (ETF) (NYSEARCA:IWO) ended its recent business day with the tumbled of -0.87% and closed at the price of $133.79 after opening at $135.55. The stock traded during its last trading session with the total volume of 1.02 million shares, as compared to its average volume of 182,501.00 shares. iShares Russell 2000 Growth ETF (the Fund), formerly iShares Russell 2000 Growth Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Russell 2000 Growth Index (the Index).
Has IWO Found The Bottom And Ready To Gain Momentum? Find Out Here
Advance Auto Parts, Inc. (NYSE:AAP) remained among the day bearish -0.96% and traded with volume of 1.03 million shares in the last session, as compared to average volume of 870,325.00 shares. In comparison with 52 week range of $71.48 - $114.33, it faced lowest price of $111.44 during the last trading session whereas its day highest price was $113.91. The company’s total market capitalization is $8.14 billion, along with 72.83 million shares outstanding. Advance Auto Parts, Inc., through its subsidiaries, operates as a specialty retailer of automotive aftermarket parts, accessories, batteries, and maintenance items.
Why Should Investors Buy AAP After the Recent Fall? Just Go Here and Find Out
Biogen Idec Inc (NASDAQ:BIIB) showed 1.02 million shares in volume during the last trading session, while the average trading volume remained 1.27 million shares. The stock kicked off its trading session at $278.03 and closed at $274.97 after dropped -0.88%. Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally.
Will BIIB Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)